16.10.2014 Views

State of the World's Children 2013 - Unicef

State of the World's Children 2013 - Unicef

State of the World's Children 2013 - Unicef

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Countries<br />

Use <strong>of</strong> improved<br />

drinking water<br />

sources (%) 2010<br />

Use <strong>of</strong> improved<br />

sanitation facilities<br />

(%) 2010<br />

Routine<br />

EPI<br />

vaccines<br />

financed<br />

by govt.<br />

Immunization coverage (%)<br />

2011<br />

Pneumonia (%)<br />

2007-2012*<br />

Diarrhoea<br />

(%)<br />

2007-2012*<br />

Malaria (%)<br />

2007-2012*<br />

and areas<br />

(%)<br />

rehydration<br />

total urban rural total urban rural 2011 BCG DPT1 b DPT3 b Polio3 MCV HepB3 Hib3<br />

pneumonia salts (ORS)<br />

United Kingdom 100 100 100 100 100 100 – – 98 95 95 90 – 95 – – – – – – –<br />

United Republic<br />

<strong>of</strong> Tanzania 53 79 44 10 20 7 23 99 96 90 88 93 90 90 88 71 – 44 59 64 64<br />

United <strong>State</strong>s 99 100 94 100 100 99 – – 98 94 94 90 91 88 – – – – – – –<br />

Uruguay 100 100 100 100 100 99 – 99 99 95 95 95 95 95 – – – – – – –<br />

Uzbekistan 87 98 81 100 100 100 – 99 99 99 99 99 99 99 – 68 x 56 x 28 x _ – –<br />

Vanuatu 90 98 87 57 64 54 16 81 78 68 67 52 59 – 75 – – 23 53 56 68<br />

Venezuela (Bolivarian<br />

Republic <strong>of</strong>) – – – – – – – 95 90 78 78 86 78 78 50 72 x – 38 x – – –<br />

Viet Nam 95 99 93 76 94 68 30 98 97 95 96 96 95 95 87 73 68 47 1 9 10<br />

Yemen 55 72 47 53 93 34 13 59 89 81 81 71 81 81 66 44 x 38 x 33 x – – –<br />

Zambia 61 87 46 48 57 43 19 88 87 81 83 83 81 81 81 68 47 60 34 50 64<br />

Zimbabwe 80 98 69 40 52 32 – 98 99 99 99 92 93 93 66 48 31 21 2 10 29<br />

MEMORANDUM<br />

Sudan and South Sudan s 58 † 67 † 52 † 26 † 44 † 14 † – – – – – – – – – – – – – – –<br />

Newborns<br />

protected<br />

against<br />

tetanus l<br />

Careseeking<br />

for<br />

suspected<br />

pneumonia<br />

Antibiotic<br />

treatment<br />

for<br />

suspected<br />

Treatment<br />

with oral<br />

TABLE 3<br />

Antimalarial<br />

treatment<br />

among<br />

febrile<br />

children<br />

<strong>Children</strong><br />

sleeping<br />

under<br />

ITNs<br />

HEALTH<br />

Households<br />

with at<br />

least<br />

one ITN<br />

SUMMARY INDICATORS #<br />

Sub-Saharan Africa 61 83 49 30 43 23 27 79 79 71 76 74 70 60 76 49 34 32 38 38 50<br />

Eastern and<br />

Sou<strong>the</strong>rn Africa 61 87 50 35 54 27 39 85 85 79 79 79 76 76 81 55 30 39 31 41 54<br />

West and Central Africa 62 82 47 26 35 20 17 73 71 62 72 69 63 44 72 44 33 27 42 36 49<br />

Middle East and<br />

North Africa 86 93 76 82 91 70 75 93 96 92 92 90 91 48 85 – – – – – –<br />

South Asia 90 96 88 38 60 28 90 87 85 75 73 77 57 23 85 65 24 34 7 – –<br />

East Asia and Pacific 90 97 84 67 77 58 95 95 95 91 92 95 89 10 85 ** 64 ** – 43 ** – 6 ** –<br />

Latin America<br />

and Caribbean 94 98 81 79 84 60 – 95 96 92 92 93 90 90 85 – – – – – –<br />

CEE/CIS 96 99 91 85 87 80 – 96 95 92 93 94 89 58 – – – – – – –<br />

Least developed countries 63 82 56 35 48 30 19 82 87 78 79 76 75 74 81 50 43 42 36 41 53<br />

World 89 96 81 63 79 47 84 88 89 83 84 84 75 43 82 ** 60 ** 31 ** 35 ** 19 ** – –<br />

s Due to <strong>the</strong> cession in July 2011 <strong>of</strong> <strong>the</strong> Republic <strong>of</strong> South Sudan by <strong>the</strong> Republic <strong>of</strong> <strong>the</strong> Sudan, and its subsequent admission to <strong>the</strong> United Nations on 14 July 2011, disaggregated data for <strong>the</strong> Sudan and South Sudan as separate<br />

<strong>State</strong>s are not yet available for all indicators. Aggregated data presented are for <strong>the</strong> Sudan pre-cession (see Memorandum item).<br />

# For a complete list <strong>of</strong> countries and areas in <strong>the</strong> regions, subregions and country categories, see page 98.<br />

DEFINITIONS OF THE INDICATORS<br />

Use <strong>of</strong> improved drinking water sources – Percentage <strong>of</strong> <strong>the</strong> population using any <strong>of</strong> <strong>the</strong> following as <strong>the</strong><br />

main drinking water source: drinking water supply piped into dwelling, plot, yard or neighbour’s yard; public tap or<br />

standpipe; tube well or borehole; protected dug well; protected spring; rainwater; bottled water plus one <strong>of</strong> <strong>the</strong><br />

previous sources as a secondary source.<br />

Use <strong>of</strong> improved sanitation facilities – Percentage <strong>of</strong> <strong>the</strong> population using any <strong>of</strong> <strong>the</strong> following sanitation facilities,<br />

not shared with o<strong>the</strong>r households: flush or pour-flush latrine connected to a piped sewerage system, septic tank or pit<br />

latrine; ventilated improved pit latrine; pit latrine with a slab; covered pit; composting toilet.<br />

Routine EPI vaccines financed by government – Percentage <strong>of</strong> EPI vaccines that are routinely administered in<br />

a country to protect children and are financed by <strong>the</strong> national government (including loans).<br />

EPI – Expanded programme on immunization: The immunizations in this programme include those against<br />

tuberculosis (TB); diph<strong>the</strong>ria, pertussis (whooping cough) and tetanus (DPT); polio; and measles, as well as<br />

vaccination <strong>of</strong> pregnant women to protect babies against neonatal tetanus. O<strong>the</strong>r vaccines, e.g., against hepatitis B<br />

(HepB), Haemophilus influenzae type b (Hib) or yellow fever, may be included in <strong>the</strong> programme in some countries.<br />

BCG – Percentage <strong>of</strong> live births who received bacille Calmette-Guérin (vaccine against tuberculosis).<br />

DPT1 – Percentage <strong>of</strong> surviving infants who received <strong>the</strong>ir first dose <strong>of</strong> diph<strong>the</strong>ria, pertussis and tetanus vaccine.<br />

DPT3 – Percentage <strong>of</strong> surviving infants who received three doses <strong>of</strong> diph<strong>the</strong>ria, pertussis and tetanus vaccine.<br />

Polio3 – Percentage <strong>of</strong> surviving infants who received three doses <strong>of</strong> <strong>the</strong> polio vaccine.<br />

MCV – Percentage <strong>of</strong> surviving infants who received <strong>the</strong> first dose <strong>of</strong> <strong>the</strong> measles-containing vaccine.<br />

HepB3 – Percentage <strong>of</strong> surviving infants who received three doses <strong>of</strong> hepatitis B vaccine.<br />

Hib3 – Percentage <strong>of</strong> surviving infants who received three doses <strong>of</strong> Haemophilus influenzae type b vaccine.<br />

Newborns protected against tetanus – Percentage <strong>of</strong> newborns protected at birth against tetanus.<br />

Care-seeking for suspected pneumonia – Percentage <strong>of</strong> children under age 5 with suspected pneumonia<br />

(cough and fast or difficult breathing due to a problem in <strong>the</strong> chest) in <strong>the</strong> two weeks preceding <strong>the</strong> survey and who<br />

were taken to an appropriate health-care provider.<br />

Antibiotic treatment for suspected pneumonia – Percentage <strong>of</strong> children under age 5 with suspected<br />

pneumonia (cough and fast or difficult breathing due to a problem in <strong>the</strong> chest) in <strong>the</strong> two weeks preceding <strong>the</strong><br />

survey who received antibiotics.<br />

Diarrhoea treatment with oral rehydration salts (ORS) – Percentage <strong>of</strong> children under age 5 who had<br />

diarrhoea in <strong>the</strong> two weeks preceding <strong>the</strong> survey and who received oral rehydration salts (ORS packets or<br />

pre-packaged ORS fluids).<br />

Antimalarial treatment among febrile children – Percentage <strong>of</strong> children under age 5 who were ill with fever in<br />

<strong>the</strong> two weeks preceding <strong>the</strong> survey and received any antimalarial medicine. NB: This indicator refers to antimalarial<br />

treatment among all febrile children, ra<strong>the</strong>r than among confirmed malaria cases, and thus should be interpreted<br />

with caution. For more information, please refer to http://www.childinfo.org/malaria_maltreatment.php.<br />

<strong>Children</strong> sleeping under ITNs – Percentage <strong>of</strong> children under age 5 who slept under an insecticide-treated<br />

mosquito net <strong>the</strong> night prior to <strong>the</strong> survey.<br />

Households with at least one ITN – Percentage <strong>of</strong> households with at least one insecticide-treated mosquito net.<br />

MAIN DATA SOURCES<br />

Use <strong>of</strong> improved drinking water sources and improved sanitation facilities – UNICEF and<br />

World Health Organization (WHO), Joint Monitoring Programme.<br />

Routine EPI vaccines financed by government – As reported by governments on UNICEF and<br />

WHO Joint Reporting Form.<br />

Immunization – UNICEF and WHO.<br />

Suspected pneumonia care-seeking and treatment – Demographic and Health Surveys (DHS),<br />

Multiple Indicator Cluster Surveys (MICS) and o<strong>the</strong>r national household surveys.<br />

Diarrhoea treatment – DHS, MICS and o<strong>the</strong>r national household surveys.<br />

Malaria prevention and treatment – DHS, MICS, Malaria Indicator Surveys (MIS) and o<strong>the</strong>r<br />

national household surveys.<br />

NOTES<br />

– Data not available.<br />

x Data refer to years or periods o<strong>the</strong>r than those specified in <strong>the</strong> column heading. Such data are not<br />

included in <strong>the</strong> calculation <strong>of</strong> regional and global averages, with <strong>the</strong> exception <strong>of</strong> 2005–2006 data<br />

from India. Estimates from data years prior to 2000 are not displayed.<br />

b Coverage for DPT1 should be at least as high as DPT3. Discrepancies where DPT1 coverage is less<br />

than DPT3 reflect deficiencies in <strong>the</strong> data collection and reporting process. UNICEF and WHO are<br />

working with national and territorial systems to eliminate <strong>the</strong>se discrepancies.<br />

l WHO and UNICEF have employed a model to calculate <strong>the</strong> percentage <strong>of</strong> births that can be<br />

considered as protected against tetanus because pregnant women were given two doses or<br />

more <strong>of</strong> tetanus toxoid (TT) vaccine. The model aims to improve <strong>the</strong> accuracy <strong>of</strong> this indicator by<br />

capturing or including o<strong>the</strong>r potential scenarios where women might be protected (e.g., women<br />

who receive doses <strong>of</strong> TT in supplemental immunization activities). A fuller explanation <strong>of</strong> <strong>the</strong><br />

methodology can be found at .<br />

† The WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation (JMP) closed its<br />

databases for <strong>the</strong>se estimates before <strong>the</strong> cession <strong>of</strong> <strong>the</strong> Republic <strong>of</strong> South Sudan by <strong>the</strong> Republic<br />

<strong>of</strong> <strong>the</strong> Sudan. Aggregated data presented are for <strong>the</strong> Sudan pre-cession. Disaggregated data for<br />

<strong>the</strong> Sudan and South Sudan as separate <strong>State</strong>s will be published by <strong>the</strong> JMP in <strong>2013</strong>.<br />

* Data refer to <strong>the</strong> most recent year available during <strong>the</strong> period specified in <strong>the</strong> column heading.<br />

** Excludes China.<br />

STATISTICAL TABLES 111

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!